|

AZD8205 in combination with AZD9574 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • AstraZeneca1

Indications

  • Biliary Tract Carcinoma1
  • Squamous Non-small-cell Lung Cancer1
  • Endometrial Cancer1
  • Ovarian Cancer1
  • Lung Cancer1

Duarte, California1 trial

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Research Site

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.